Download Free Medical Management of Rotator Cuff Injuries PowerPoint Presentation

Management of Rotator Cuff Injuries PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Orthopedic Surgery, which is titled "Management of Rotator Cuff Injuries", to know about the Evidence-Based Clinical Practice Guideline for the Management of Rotator Cuff Injuries.

Tags : Orthopedic Surgery, Management, Rotator Cuff Injuries

Published on : Jul 20, 2021 | Views : 2112 | Downloads : 1

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Management of Rotator Cuff Injuries: Evidence-Based Clinical Practice Guideline Adopted by the American Academy of Orthopaedic Surgeons (AAOS) Board of Directors March 11, 2019
Slide 2-

© 2018 American Academy of Orthopaedic Surgeons WHAT IS A CLINICAL PRACTICE GUIDELINE? Clinical Practice Guideline A clinical practice guideline is a series of recommendations created to inform clinicians of best practices, based on best available evidence
Slide 3-

GOALS AND RATIONALE OF A CLINICAL PRACTICE GUIDELINE Improve treatment based on current best evidence Guides qualified physicians through treatment decisions to improve quality and efficiency of care Identify areas for future research CPG recommendations are not meant to be fixed protocols; patients’ needs, local resources, and clinician independent medical judgement must be considered for any specific procedure or treatment © 2018 American Academy of Orthopaedic Surgeons
Slide 4-

WHAT IS EVIDENCE-BASED MEDICINE? © 2018 American Academy of Orthopaedic Surgeons Evidence-Based Medicine is a Combination of: Individual Clinical Experience Best External Evidence Patient Values and Expectations EBM
Slide 5-

WHAT IS EVIDENCE-BASED MEDICINE? © 2018 American Academy of Orthopaedic Surgeons Evidence-Based Medicine Evidence-based medicine is the conscientious, explicit, and judicious use of current best evidence from clinical care research in the management of individual patients Haynes, Sackett et al, 1996 Transferring evidence from research into practice Sacket et al, 1996, BMJ EBM: what it is and isn’t
Slide 6-

© 2018 American Academy of Orthopaedic Surgeons IOM STANDARDS FOR DEVELOPING TRUSTWORTHY GUIDELINES Establish Transparency Management of Conflict of Interest Guideline Development Group Composition Clinical Practice Guideline-Systematic Review Intersection Establish Evidence of Foundations for and Rating Strength of Recommendations Articulation of Recommendations External Review Updating
Slide 7-

© 2018 American Academy of Orthopaedic Surgeons CLINICAL PRACTICE GUIDELINE PROCESS FLOWCHART
Slide 8-

© 2018 American Academy of Orthopaedic Surgeons FORMULATING PICOs
Slide 9-

© 2018 American Academy of Orthopaedic Surgeons INCLUSION/EXCLUSION CRITERIA Standard inclusion criteria include: Must study humans Must be published in English Must be published in or after 1966 Can not be performed on cadavers Work group members define additional exclusion criteria based on PICO question Exclusion Criteria
Slide 10-

© 2018 American Academy of Orthopaedic Surgeons LITERATURE SEARCHES Databases used: PubMed EMBASE (Excerpta Medica dataBASE) CINAHL (Cumulative Index of Nursing and Allies Health Literature) Cochrane Central Register of Controlled Trials Search using key terms from work group’s PICO questions and inclusion criteria Secondary manual search of the bibliographies of all retrieved publications for relevant citations Recalled articles evaluated for inclusion based on the study selection criteria
Slide 11-

© 2018 American Academy of Orthopaedic Surgeons BEST EVIDENCE SYNTHESIS Include only highest quality evidence for any given outcome if available If there are fewer than two occurrences of an outcome of this quality, the next lowest quality is considered until at least two occurrences have been acquired.
Slide 12-

© 2018 American Academy of Orthopaedic Surgeons STRENGTH OF RECOMMENDATIONS
Slide 13-

© 2018 American Academy of Orthopaedic Surgeons TRANSLATING RECOMMENDATIONS IN A CPG
Slide 14-

© 2018 American Academy of Orthopaedic Surgeons ASSESSING QUALITY OF EVIDENCE All included studies undergo a quality assessment. Each study’s design is evaluated for risk of bias and receives a final quality grade, depending on the number of study design flaws. Study quality tables are made available to the work group in the final data report and the final publication of the guideline/SR
Slide 15-

© 2018 American Academy of Orthopaedic Surgeons RESULTS OF QUALITY ASSESSMENT: STUDY ATTRITION FLOWCHART 8904 articles excluded from title and abstract review 9496 abstracts reviewed. Primary search performed on June 26th 2017 2115 articles recalled for full text review 1902 articles excluded after full text review for not meeting the a priori inclusion criteria or not best evidence available 213 articles included after full text review and quality analysis 1555 abstracts reviewed. Secondary search performed on June 6th 2018
Slide 16-

© 2018 American Academy of Orthopaedic Surgeons VOTING ON THE RECOMMENDATIONS Recommendations and recommendation strengths voted on by work group during final meeting Approved and adopted by simple majority (60%) when voting on every recommendation If disagreement, further discussion to whether the disagreement could be resolved
Slide 17-

© 2018 American Academy of Orthopaedic Surgeons GUIDELINE LANGUAGE STEMS
Slide 18-

© 2018 American Academy of Orthopaedic Surgeons PEER REVIEW Guideline draft sent for peer review to external experts Comments and draft of responses reviewed by work group members Recommendation changes required a majority vote by work group A detailed report of all resulting revisions is published with the guideline document
Slide 19-

© 2018 American Academy of Orthopaedic Surgeons PUBLIC COMMENT Following peer review modifications, CPG undergoes public commentary period Comments are solicited from: AAOS Board of Directors AAOS Council on Research and Quality AAOS Committee on Evidence-Based Quality and Value AAOS Board of Councilors AAOS Board of Specialty Societies 200 commentators have the opportunity to provide input
Slide 20-

© 2018 American Academy of Orthopaedic Surgeons FINAL MEETING The work group is charged with: Review of data summaries Final recommendation language Rationale and risk/harm construction Future research
Slide 21-

MANAGEMENT OF ROTATOR CUFF INJURIESCLINICAL PRACTICE GUIDELINE OVERVIEW Based on a systematic review of published studies Addresses the management of rotator cuff tears in adults. Highlights limitations in literature and areas requiring future research Trained physicians and surgeons are intended users © 2018 American Academy of Orthopaedic Surgeons
Slide 22-

© 2018 American Academy of Orthopaedic Surgeons MANAGEMENT OF SMALL TO MEDIUM TEARS Strong evidence supports that both physical therapy and operative treatment result in significant improvement in patient-reported outcomes for patients with symptomatic small to medium full-thickness rotator cuff tears. Strength of Recommendation: Strong
Slide 23-

© 2018 American Academy of Orthopaedic Surgeons LONG TERM NON-OPERATIVE MANAGEMENT Strong evidence supports that patient reported outcomes (PRO) improve with physical therapy in symptomatic patients with full thickness rotator cuff tears. However, the rotator cuff tear size, muscle atrophy, and fatty infiltration may progress over 5 to 10 years with non operative management. Strength of Recommendation: Strong
Slide 24-

© 2018 American Academy of Orthopaedic Surgeons OPERATIVE MANAGEMENT Moderate evidence supports that healed rotator cuff repairs show improved patient-reported and functional outcomes compared to physical therapy and unhealed rotator cuff repairs. Strength of Recommendation: Moderate
Slide 25-

© 2018 American Academy of Orthopaedic Surgeons ACROMIOPLASTY & ROTATOR CUFF REPAIR Moderate strength evidence does not support the routine use of acromioplasty as a concomitant treatment as compared to arthroscopic repair alone for patients with small to medium sized full-thickness rotator cuff tears.
Slide 26-

© 2018 American Academy of Orthopaedic Surgeons DISTAL CLAVICLE RESECTION Moderate strength evidence supports the use of distal clavicle resection as a concomitant treatment to arthroscopic repair for patients with full-thickness rotator cuff tears and symptomatic acromioclavicular joints. Strength of Recommendation: Moderate
Slide 27-

© 2018 American Academy of Orthopaedic Surgeons DIAGNOSIS (CLINICAL EXAMINATION) Strong evidence supports that clinical examination can be useful to diagnose or stratify patients with rotator cuff tears; however, combination of tests will increase diagnostic accuracy. Strength of Recommendation: Strong
Slide 28-

© 2018 American Academy of Orthopaedic Surgeons DIAGNOSIS (IMAGING) Strong evidence supports that MRI, MRA, and ultrasound are useful adjuncts to a clinical exam for identifying rotator cuff tears.
Slide 29-

© 2018 American Academy of Orthopaedic Surgeons POST-OP MOBILIZATION TIMING Strong evidence suggests similar postoperative clinical and patient-reported outcomes for small to medium sized full-thickness rotator cuff tears between early mobilization and delayed mobilization up to 8 weeks for patients who have undergone arthroscopic rotator cuff repair.
Slide 30-

© 2018 American Academy of Orthopaedic Surgeons CORTICOSTEROID INJECTIONS FOR ROTATOR CUFF TEARS Moderate evidence supports the use of a single injection of corticosteroids with local anesthetic for short-term improvement in both pain and function for patients with shoulder pain. Strength of Recommendation: Moderate
Slide 31-

© 2018 American Academy of Orthopaedic Surgeons HYALURONIC ACID INJECTIONS FOR ROTATOR CUFF TEARS Limited evidence supports for the possible use of hyaluronic acid injections in the non-operative management of rotator cuff pathology with no tears. Strength of Recommendation: Limited
Slide 32-

© 2018 American Academy of Orthopaedic Surgeons PLATELET RICH PLASMA (PRP) INJECTION IN PARTIAL-THICKNESS TEARS Limited evidence does not support the routine use of platelet rich plasma for the treatment of cuff tendonopathy or partial tears. Strength of Recommendation: Limited
Slide 33-

© 2018 American Academy of Orthopaedic Surgeons HIGH-GRADE PARTIAL THICKNESS ROTATOR CUFF TEARS Strong evidence supports the use of either conversion to full-thickness or transtendinous/in-situ repair in patients that failed conservative management with high-grade partial thickness rotator cuff tears.
Slide 34-

© 2018 American Academy of Orthopaedic Surgeons PROGNOSTIC FACTORS (AGE) Strong evidence supports that older age is associated with higher failure rates and poorer patient reported outcomes after rotator cuff repair.
Slide 35-

© 2018 American Academy of Orthopaedic Surgeons PROGNOSTIC FACTORS (HIGHER BMI) Moderate evidence supports that higher BMI is correlated with higher re-tear rates after rotator cuff repair surgery; however, strong evidence supports that there is no correlation between higher BMI and worse patient-reported outcomes following rotator cuff repair.
Slide 36-

© 2018 American Academy of Orthopaedic Surgeons PROGNOSTIC FACTORS (WORKER’S COMPENSATION) Strong evidence supports the presence of a worker’s compensation claim is associated with poorer patient reported outcomes after rotator cuff repair.
Slide 37-

© 2018 American Academy of Orthopaedic Surgeons PROGNOSTIC FACTORS (COMORBIDITIES) Moderate evidence supports the association of poorer patient reported outcomes in patient with more comorbidities
Slide 38-

© 2018 American Academy of Orthopaedic Surgeons PROGNOSTIC FACTORS (DIABETES) Moderate evidence suggests that patients with diabetes will have higher re-tear rates and poorer quality of life and patient reported outcome scores after rotator cuff repair.
Slide 39-

© 2018 American Academy of Orthopaedic Surgeons PROGNOSTIC FACTORS (PATIENT EXPECTATIONS) Moderate evidence correlates higher preoperative patient expectations for surgery with higher patient reported outcomes after rotator cuff repair.
Slide 40-

© 2018 American Academy of Orthopaedic Surgeons BIOLOGICAL AUGMENTATION WITH PLATELET DERIVED PRODUCTS Strong evidence does not support biological augmentation of rotator cuff repair with platelet-derived products on improving patient reported outcomes; however, limited evidence supports the use of liquid platelet rich plasma (PRP) in the context of decreasing re-tear rates.
Slide 41-

© 2018 American Academy of Orthopaedic Surgeons SINGLE-ROW VS DOUBLE-ROW REPAIR Strong evidence does not support double row rotator cuff repair constructs on improving patient-reported outcomes compared to single row vertical mattress repair constructs.
Slide 42-

© 2018 American Academy of Orthopaedic Surgeons SINGLE-ROW VS DOUBLE-ROW REPAIR RE-TEARS Strong evidence supports lower re-tear rates after double row repair compared to single row vertical mattress repair when evaluating for both partial and full thickness retears after primary repair; however, when evaluating the data for only full thickness retears, limited evidence does not support lower re-tear rates after double row primary repair.
Slide 43-

© 2018 American Academy of Orthopaedic Surgeons MARROW STIMULATION Limited evidence suggests that marrow stimulation at the time of rotator cuff repair does not improve patient-reported outcomes; however, this technique may decrease re-tear rates in patients with larger tear sizes. Strength of Recommendation: Limited
Slide 44-

© 2018 American Academy of Orthopaedic Surgeons DERMAL ALLOGRAFTS Limited evidence supports the use of dermal allografts to augment the repair of large and massive rotator cuff tears to improve patient reported outcomes. Strength of Recommendation: Limited
Slide 45-

© 2018 American Academy of Orthopaedic Surgeons XENOGRAFTS Limited evidence does not support the use of xenografts to augment the repair of large and massive rotator cuff tears. Strength of Recommendation: Limited
Slide 46-

© 2018 American Academy of Orthopaedic Surgeons OPEN VS ARTHROSCOPIC REPAIRS Strong evidence supports no difference in long-term (> 1 year) patient-reported outcomes or cuff healing rates between open and arthroscopic repairs; however, arthroscopic-only technique is associated with better short-term improvement in post operative recovery of motion and decreased visual analog scale (VAS) scores.
Slide 47-

© 2018 American Academy of Orthopaedic Surgeons POSTOPERATIVE PAIN MANAGEMENT Moderate strength evidence supports the use of multimodal programs or non-opioid individual modalities to provide added benefit for postoperative pain management following rotator cuff repair.
Slide 48-

© 2018 American Academy of Orthopaedic Surgeons SUPERVISED EXERCISE VS UNSUPERVISED EXERCISE In the absence of reliable evidence, it is the opinion of the work group that supervised physical therapy is more appropriate than unsupervised home exercise for some patients following rotator cuff repair.
Slide 49-

© 2018 American Academy of Orthopaedic Surgeons MULTIPLE STEROID INJECTIONS FOR ROTATOR CUFF TEARS In the absence of reliable evidence, it is the opinion of the work group that multiple steroid injections may compromise the integrity of the rotator cuff, which may affect attempts at subsequent repair.
Slide 50-

© 2018 American Academy of Orthopaedic Surgeons PLATELET RICH PLASMA (PRP) INJECTION IN FULL-THICKNESS TEARS In the absence of reliable evidence, it is the consensus of the work group that we do not recommend the routine use of PRP in the non-operative management of full-thickness rotator cuff tears.
Slide 51-

© 2018 American Academy of Orthopaedic Surgeons PARTIAL ROTATOR CUFF TEAR In the absence of reliable evidence, the work group is unable to define a preference for the choice of debridement versus repair of high-grade partial-thickness cuff tears that have failed physical therapy, however repair of high grade partial tears could improve outcomes.
Slide 52-

© 2018 American Academy of Orthopaedic Surgeons UNREPAIRABLE TEARS WITHOUT ARTHROPATHY (NON-REVERSE ARTHROPLASTY) In the absence of reliable evidence, it is the opinion of the work group that physical therapy, biceps tenotomy/tenodesis, partial repair, tendon transfer, superior capsular reconstruction, arthroscopic debridement, or graft augmentation (non-porcine) can improve patient reported outcomes.
Slide 53-

© 2018 American Academy of Orthopaedic Surgeons MASSIVE, UNREPAIRABLE ROTATOR CUFF TEAR (REVERSE ARTHROPLASTY) In the absence of reliable evidence, it is the opinion of the work group that in patients with massive, unrepairable tears and significant functional loss who have failed other treatments, reverse arthroplasty can improve patient reported outcomes.
Slide 54-

© 2018 American Academy of Orthopaedic Surgeons UNREPAIRABLE TEARS WITH ARTHROPATHY In the absence of reliable evidence, it is the opinion of the workgroup that after failure of conservative treatment, reverse shoulder arthroplasty for unrepairable tears with glenohumeral joint arthritis can improve patient reported outcomes..
Slide 55-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH Consideration for future research is provided for each recommendation within this document. High quality studies comparing the outcomes of operative and non-treatment of rotator cuff pathology of all types remains a major gap in knowledge. These need to continue out to five years, to fully understand the efficacy of each treatment. Future studies should focus more on strengthening the literature for the association between RCTs and factors such as diabetes mellitus, hypertension, cholesterol, smoking and BMI. Questions persist regarding the timing of physical therapy after surgery, and the need for formal therapy versus a supervised home program. While widely employed in practice, the risks and benefits of corticosteroid injections in patients with rotator cuff tears remain unclear. The repair of high-grade partial rotator cuff tears has been widely adopted by the orthopedic community, but there exists minimal evidence to support this choice.
Slide 56-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH The risk and expense of orthobiologics in rotator cuff surgery remains difficult to fully assess, even though multiple high quality studies are currently available. The use of either allograft or xenograft patches to either augment rotator cuff repair or as a superior capsular reconstruction requires additional high quality studies to prove efficacy. Finally, given the opioid epidemic, high-quality studies of multimodal analgesia for rotator cuff surgery would seem to be a matter of public policy. Consideration for future research is provided for each recommendation within this document. High-strength, level one studies comparing the outcomes of operative and non-treatment of rotator cuff pathology of all types remains a major gap in knowledge. Future studies should focus more on strengthening the literature for the association between RCTs and factors such as diabetes mellitus, hypertension, smoking and BMI.
Slide 57-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – LONG TERM NON-OPERATIVE MANAGEMENT Continued long term comparative studies between physical therapy and surgical repair investigating larger tear sizes with pre-and postoperative advanced imaging studies. It is still unclear what factors influence tear progression and if tear progression advances enough to preclude future repair and subsequent resolution of symptoms.
Slide 58-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – OPERATIVE MANAGEMENT Continued long term comparative studies between physical therapy and surgical repair investigating larger tear sizes with pre-and postoperative advanced imaging studies. The long-term consequences of a persistent rotator cuff tear or a re-tear is currently not known.
Slide 59-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – ACROMIOPLASTY& ROTATOR CUFF REPAIR Continued long term comparative studies between physical therapy and surgical repair investigating larger tear sizes with pre-and postoperative advanced imaging studies. The long-term consequences of a persistent rotator cuff tear or a re-tear is currently not known.
Slide 60-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH DISTAL CLAVICLE RESECTION / DIAGNOSIS (CLINICAL EXAMINATION Future research could be performed to elucidate risk factors for reoperation rates in certain groups who did not undergo concomitant procedures.
Slide 61-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – POST-OP MOBILIZATION TIMING This question centers on the timing of post-operative mobilization exercises, defined in the 6 studies reviewed here, as the initiation of supervised physical therapy. Although easy to quantify, a physical therapy visit may not be the measure most indicative of stress on the healing repair. Absolute load and cyclic loading have been identified as factors affecting suture durability in biomechanical studies.
Slide 62-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – CORTICOSTEROID INJECTIONS Further research is recommended to determine the role of corticosteroid injections in the various settings of rotator cuff pathology. Currently there is no high quality studies specifically addressing the role of corticosteroid injections in partial and / or full thickness cuff tears.
Slide 63-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – HYALURONIC ACID INJECTIONS Further research may be conducted to further define the role of hyaluronic acid injections in rotator cuff pathology.
Slide 64-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – PLATELET RICH PLASMA (PRP) INJECTION IN PARTIAL-THICKNESS TEARS Further research may be conducted to further define the role of PRP injections in rotator cuff pathology. Future studies should standardize the type of PRP formulation utilized or at the very least measure the concentrations of key constituents.
Slide 65-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – HIGH-GRADE PARTIAL THICKNESS ROTATOR CUFF TEARS Additional high quality level one studies with longer follow-up would be useful to establish if the results of these techniques hold up with time. Larger studies might also establish risk of retear with differing techniques.
Slide 66-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – PROGNOSTIC FACTORS Age: Degenerative rotator cuff disease is a phenomenon of aging, yet there is great variability in this phenomenon. Future research is needed to distinguish chronological age from physiologic age, and healing will likely improve when age related changes to the rotator cuff are better understood and manipulated. BMI: Patients with higher BMI generally start with lower scores on patient reported outcome measures. Future research should investigate if this starting point changes with weight loss, and how this affects the improvement in patient reported outcomes after surgery. Patient Expectations: There is currently very little research on optimal ways to evaluate and influence patient expectation.
Slide 67-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – PROGNOSTIC FACTORS Comorbidities: While the number of comorbidities does influence patient reported outcomes after rotator cuff repair surgery, it would be important to understand the risk stratification of specific comorbidities to accurately make recommendations about the expected outcomes. Diabetes: Future research should determine if adequate control of diabetes will improve patient reported outcomes and improve healing after rotator cuff repair. Worker’s Compensation: It would be important to know what features (job satisfaction, manual labor job, resiliency, etc.) might predict poorer patient reported outcomes after rotator cuff repair in the population of worker’s compensation patients.
Slide 68-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – BIOLOGICAL AUGMENTATION WITH PLATELET DERIVED PRODUCTS Future studies should standardize the type of PRP formulation utilized or at the very least measure the concentrations of key constituents. Furthermore, larger studies will allow for controlled statistical analyses that consider the effect of confounders such as fixation constructs, marrow venting, size of tears, etc. Consistency in the definition of rotator cuff re-tear is also encouraged.
Slide 69-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – SINGLE-ROW VS DOUBLE-ROW REPAIR Future research needs to be performed to evaluate for both PROs and failure rates on imaging and reoperation rates between single row compared to double row repair for larger full thickness rotator cuff tears >3cm in size.
Slide 70-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – SINGLE-ROW VS DOUBLE-ROW REPAIR RE-TEARS Future research should be performed to evaluate for failure rates on imaging and reoperation rates between single row compared to double row repair for full thickness rotator cuff tears. Research also needs to be done to better identify the clinical significance of a partial thickness re-tear after arthroscopic rotator cuff repair.
Slide 71-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – MARROW STIMULATION Future studies should be large enough such that the statistical analyses will allow for consideration of confounders such as fixation constructs, size of tears, etc.. Consistency in the definition of a rotator cuff re-tear is also encouraged.
Slide 72-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – DERMAL ALLOGRAFTS Given the risks and costs involved with these devices, high quality studies would be useful to definitively establish the benefits of these device.
Slide 73-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – XENOGRAFTS While the evidence available to recommend for or against xenograft augmentation is mixed, the absence of clear benefit associated with these grafts, and the increased incidence of post-operative reaction coupled with the absence of reports of these reactions with allograft augment would seem to indicate that further research is not warranted at this time on xenografts in their current form.
Slide 74-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – OPEN VS ARTHROSCOPIC REPAIRS Given the conflicting information available regarding improvements in post-operative pain and early recovery with all-arthroscopic repair, further studies are needed in this area to establish benefits of this procedure.
Slide 75-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – POSTOPERATIVE PAIN MANAGEMENT The analysis of this question has exposed the need for future research particular into the pros and cons of each medication, modality, and multimodal program as they are compared to each other. The collective data and indirect comparisons from the high quality articles cited in this recommendation could be used to perform a network meta-analysis, providing valuable information to best guide future management.
Slide 76-

© 2018 American Academy of Orthopaedic Surgeons FUTURE RESEARCH – PARTIAL ROTATOR CUFF TEAR High strength comparative studies between debridement and partial tear repair may further clarify the utility of these two techniques in managing partial rotator cuff tears.
Slide 77-

© 2018 American Academy of Orthopaedic Surgeons This Guideline has been endorsed by the following organizations:
Slide 78-

© 2018 American Academy of Orthopaedic Surgeons ACKNOWLEDGEMENTS: Development Group Roster: Stephen Weber, MD, Co-Chair Jaskarndip Chahal, MD, Co-Chair Shafic A. Sraj, MD Jason M. Matuszak, MD Amee L. Seitz, PhD, PT Lori A. Michener, PhD, PT, ATC Mark R. Hutchinson, MD Michael A. Shaffer, PT, ATC, OCS Xinning Lo, MD Michael M. Albrecht, MD Christopher C. Schmidt, MD John Kuhn, MD, MS Leesa Galatz, MD AAOS Guidelines Oversight Chair: Gregory A. Brown, MD, PhD AAOS Clinical Practice Guidelines Section Leader: Gregory Brown, MD, PhD AAOS Committee on Evidence-Based Quality and Value Chair: Kevin Shea, MD AAOS Council on Research and Quality Chair: Robert H. Quinn, MD AAOS Staff: William Shaffer, MD Jayson N. Murray, MA Ryan Pezold, MA Kyle Mullen, MPH Mary DeMars Mukarram Mohiuddin, MPH Syed Hussain, MS Peter Shores, MPH Anne Woznica, MLIS, AHIP Kaitlyn Sevarino, MBA
Slide 79-

© 2018 American Academy of Orthopaedic Surgeons PLEASE CITE CLINICAL PRACTICE GUIDELINE AS: American Academy of Orthopaedic Surgeons Evidence-Based Clinical Practice Guideline on the Management of Rotator Cuff Injuries. http://www.orthoguidelines.org/topic?id=1027. Published March 11, 2019.
Slide 80-

© 2018 American Academy of Orthopaedic Surgeons 80 Free for both iOS and Android or at www.orthoguidelines.org Provides easy access to all AAOS: Clinical Practice Guidelines Full Guideline PDF’s Appropriate Use Criteria Case Studies Clinician Checklists Impactful Statements Plain Language Summaries Evidence-based Databases Evidence-based Methods, Appraisals and Standards
Slide 81-

Easier access to AAOS Guidelines: Sort Alphabetically by Topic Sort Recommendations by Strength (Strong, Moderate, Limited, Consensus) Sort by Stage of Care Search Across all CPGs via a Single Keyword Search Easier Access to Individual Recommendations: View recommendations via shortened titles Access to full recommendation & rationale Links to references (PubMed) Clinical Practice Guidelines Now Available on Your Smartphone Download on the App Store Get it on Google play
Slide 82-

© 2018 American Academy of Orthopaedic Surgeons Search across all CPG and AUC Via a Single Keyword Search Imaging
Slide 83-

References provided for each recommendation Links to PubMed
Slide 84-

Appropriate Use Criteria Tool 84
Slide 85-

© 2018 American Academy of Orthopaedic Surgeons Acute Achilles Tendon Rupture Acute Compartment Syndrome Anterior Cruciate Ligament Injuries Carpal Tunnel Syndrome Diagnosis and Prevention of Periprosthetic Joint Infections Distal Radius Fractures Glenohumeral Joint Osteoarthritis Hip Fractures in the Elderly Osteoarthritis of the Hip Osteoarthritis of the Knee (Arthroplasty) Osteoarthritis of the Knee (Non-Arthroplasty) Osteochondritis Dissecans Pediatric Developmental Dysplasia of the Hip in infants up to Six Months Pediatric Diaphyseal Femur Fractures Pediatric Supracondylar Humerus Fractures Prevention of Orthopaedic Implant Infections in Patients Undergoing Dental Procedures Rotator Cuff Injuries Surgical Site Infections VTE Disease in Patients Undergoing Elective Hip & Knee Arthroplasty Tranexamic Acid in Total Joint Arthroplasty (Endorsement) Use of Imaging Prior to Referral to a Musculoskeletal Oncologist (Endorsement) For additional information, please visit http://www.orthoguidelines.org/ PUBLISHED CLINICAL PRACTICE GUIDELINES